search
Back to results

Optimal Timing of Percutaneous Intervention in Non-maturing Dialysis Fistulas

Primary Purpose

Immature Arteriovenous Fistula

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
early Angioplasty
late Angioplasty
Sponsored by
University of Alabama at Birmingham
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Immature Arteriovenous Fistula focused on measuring immature AVF, percutaneous intervention

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients with End stage renal disease (ESRD).
  • Patients on hemodialysis.
  • Patients using central venous catheter (CVC).
  • Patients who had a new AVF created after commencing dialysis.
  • Patients who had immature fistula ( 6-week postoperative ultrasound that revealed an immature AVF (diameter < 4 mm diameter or blood flow < 500 ml/min).

Exclusion Criteria:

• Children with Age below 18

Sites / Locations

  • UAB

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

early angioplasty

late Angioplasty

Arm Description

Patients who initiated hemodialysis with a CVC, then had a new AVF created after commencing dialysis, and then had a 6-week postoperative ultrasound that revealed an immature AVF (diameter < 4 mm diameter or blood flow < 500 ml/min). These patients who an early angioplasty intervention group that will undergo a routine Angioplasty at 6 weeks after AVF creation

Patients who initiated hemodialysis with a CVC, then had a new AVF created after commencing dialysis, and then had a 6-week postoperative ultrasound that revealed an immature AVF (diameter < 4 mm diameter or blood flow < 500 ml/min). These patients who a late angioplasty intervention group in which early Angioplasty will be avoided and subsequently be performed only if the 3-month ultrasound indicates persistent AVF immaturity

Outcomes

Primary Outcome Measures

Fistula Maturity
Ultrasound of the fistula: Mature fistula Criteria: Blood flow of at least 500 ml/min and Minimum diameter of 4 mm

Secondary Outcome Measures

Fistula survival
Ultrasound of the fistula: Blood flow of at least 500 ml/min and Minimum diameter of 4 mm
Fistula adequacy
Fistula is used for hemodilaysis and provide adequate clearance which is measured by: Kt/V: 1.4 where K: clearance [m3/s], t: time [m3/s], V:volume of distribution [m3]

Full Information

First Posted
July 31, 2017
Last Updated
April 24, 2020
Sponsor
University of Alabama at Birmingham
search

1. Study Identification

Unique Protocol Identification Number
NCT03245944
Brief Title
Optimal Timing of Percutaneous Intervention in Non-maturing Dialysis Fistulas
Official Title
Optimal Timing of Percutaneous Intervention in Non-maturing Dialysis Fistulas
Study Type
Interventional

2. Study Status

Record Verification Date
April 2020
Overall Recruitment Status
Completed
Study Start Date
March 1, 2018 (Actual)
Primary Completion Date
March 1, 2019 (Actual)
Study Completion Date
March 1, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Alabama at Birmingham

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Arteriovenous fistulas (AVFs) are the preferred type of vascular access for dialysis, but many of them fail to mature. The optimal timing of intervention to salvage immature AVFs is unknown.The study proposes a randomized clinical trial comparing the clinical and economic impact of early vs late angioplasty in non-maturing AVFs. The study proposes a RCT to test the hypothesis that, as compared to early angioplasty of non-maturing AVFs, late angioplasty results in a lower proportion of AVFs being used at 6 months, but a greater long-term AVF patency , lower requirement of subsequent interventions to maintain AVF patency for dialysis, and lower overall cost of access maintenance.
Detailed Description
The optimal timing of intervention in non-maturing AVFs remains controversial, and can only be definitively addressed by a randomized clinical trial (RCT) comparing early (6 weeks) vs late (3 months) angioplasty of non-maturing AVFs. The investigators will perform a single-center, prospective RCT. The investigators will recruit 112 patients who initiated hemodialysis with a CVC, then had a new AVF created after commencing dialysis, and then had a 6-week postoperative ultrasound that revealed an immature AVF (diameter < 4 mm diameter or blood flow < 500 ml/min). These patients will be randomized to one of two groups: an early intervention group that will undergo a routine PTA at 6 weeks after AVF creation, or a late intervention group in which early PTA will be avoided and subsequently be performed only if the 3-month ultrasound indicates persistent AVF immaturity. These patients will be followed for 2 years.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Immature Arteriovenous Fistula
Keywords
immature AVF, percutaneous intervention

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
8 (Actual)

8. Arms, Groups, and Interventions

Arm Title
early angioplasty
Arm Type
Active Comparator
Arm Description
Patients who initiated hemodialysis with a CVC, then had a new AVF created after commencing dialysis, and then had a 6-week postoperative ultrasound that revealed an immature AVF (diameter < 4 mm diameter or blood flow < 500 ml/min). These patients who an early angioplasty intervention group that will undergo a routine Angioplasty at 6 weeks after AVF creation
Arm Title
late Angioplasty
Arm Type
Experimental
Arm Description
Patients who initiated hemodialysis with a CVC, then had a new AVF created after commencing dialysis, and then had a 6-week postoperative ultrasound that revealed an immature AVF (diameter < 4 mm diameter or blood flow < 500 ml/min). These patients who a late angioplasty intervention group in which early Angioplasty will be avoided and subsequently be performed only if the 3-month ultrasound indicates persistent AVF immaturity
Intervention Type
Procedure
Intervention Name(s)
early Angioplasty
Other Intervention Name(s)
Early PTA
Intervention Description
Angioplasty is a minimally invasive, endovascular procedure to widen narrowed or obstructed arteries or veins. A deflated balloon attached to a catheter (a balloon catheter) is passed over a guide-wire into the narrowed vessel and then inflated to a fixed size. The balloon forces expansion of the blood vessel and the surrounding muscular wall, allowing an improved blood flow. This is part of standard of care for immature arteriovenous fistulas. Early means pt will get the procedure at 6 weeks from time of initiation of AVFs
Intervention Type
Procedure
Intervention Name(s)
late Angioplasty
Other Intervention Name(s)
Late PTA
Intervention Description
Angioplasty is a minimally invasive, endovascular procedure to widen narrowed or obstructed arteries or veins. A deflated balloon attached to a catheter (a balloon catheter) is passed over a guide-wire into the narrowed vessel and then inflated to a fixed size. The balloon forces expansion of the blood vessel and the surrounding muscular wall, allowing an improved blood flow. This is part of standard of care for immature arteriovenous fistulas. Late means the angioplasty is done at 3 months from time of AVF creation if still immature at that time.
Primary Outcome Measure Information:
Title
Fistula Maturity
Description
Ultrasound of the fistula: Mature fistula Criteria: Blood flow of at least 500 ml/min and Minimum diameter of 4 mm
Time Frame
baseline- 6 months
Secondary Outcome Measure Information:
Title
Fistula survival
Description
Ultrasound of the fistula: Blood flow of at least 500 ml/min and Minimum diameter of 4 mm
Time Frame
baseline-2 years
Title
Fistula adequacy
Description
Fistula is used for hemodilaysis and provide adequate clearance which is measured by: Kt/V: 1.4 where K: clearance [m3/s], t: time [m3/s], V:volume of distribution [m3]
Time Frame
Baseline- 2 years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients with End stage renal disease (ESRD). Patients on hemodialysis. Patients using central venous catheter (CVC). Patients who had a new AVF created after commencing dialysis. Patients who had immature fistula ( 6-week postoperative ultrasound that revealed an immature AVF (diameter < 4 mm diameter or blood flow < 500 ml/min). Exclusion Criteria: • Children with Age below 18
Facility Information:
Facility Name
UAB
City
Birmingham
State/Province
Alabama
ZIP/Postal Code
35201
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
27630181
Citation
Al-Balas A, Lee T, Young CJ, Barker-Finkel J, Allon M. Predictors of Initiation for Predialysis Arteriovenous Fistula. Clin J Am Soc Nephrol. 2016 Oct 7;11(10):1802-1808. doi: 10.2215/CJN.00700116. Epub 2016 Sep 14.
Results Reference
background
PubMed Identifier
28710090
Citation
Al-Balas A, Lee T, Young CJ, Kepes JA, Barker-Finkel J, Allon M. The Clinical and Economic Effect of Vascular Access Selection in Patients Initiating Hemodialysis with a Catheter. J Am Soc Nephrol. 2017 Dec;28(12):3679-3687. doi: 10.1681/ASN.2016060707. Epub 2017 Jul 14.
Results Reference
background

Learn more about this trial

Optimal Timing of Percutaneous Intervention in Non-maturing Dialysis Fistulas

We'll reach out to this number within 24 hrs